SCHEMBL19904577

SCHEMBL19904577

O=C(NC(Cc1ccc(O)cc1)CN1CCCC1)[C@@H]1CCN(c2ccc(Cl)cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.46
HTR1A P08908 1/20 0.45
CCR1 P32246 1/20 0.43
ME3 Q16798 2/20 0.40
ME2 P23368 1/20 0.40
ME1 P48163 1/20 0.40
CHRM4 P08173 1/20 0.39
WDR91 A4D1P6 3/20 0.39
DEGS1 O15121 1/20 0.39
GAA P10253 1/20 0.38
FFAR1 O14842 1/20 0.38
GPBAR1 Q8TDU6 2/20 0.38
MAPT P10636 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904696 0.96 NOTUM (0.50) NOTUMHTR1ACCR1WDR91GAA
SCHEMBL19904626 0.90 HTR1A (0.48) NOTUMHTR1AME3CHRM4GRIN2D
SCHEMBL19904392 0.88 ACACB (0.47) NOTUMHTR1ACCR1
SCHEMBL19904620 0.86 NOTUM (0.43) NOTUMHTR1ACCR1WDR91GAA
SCHEMBL19904517 0.85 HPGD (0.43) NOTUMHTR1ACCR1GAAMAPT
SCHEMBL18101714 0.85 KMT2A (0.49) NOTUMHTR1ACCR1GAAMAPT
SCHEMBL19904652 0.85 KMT2A (0.49) NOTUMHTR1ACCR1GAAMAPT
SCHEMBL19904475 0.85 HPGD (0.43) NOTUMHTR1ACCR1GAAMAPT
SCHEMBL18101713 0.85 KMT2A (0.49) NOTUMHTR1ACCR1GAAMAPT
SCHEMBL19904451 0.85 KMT2A (0.49) NOTUMHTR1ACCR1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed